GOLD COPD 2020 strategy
Chronic obstructive pulmonary disease (COPD) is a leading cause of death worldwide. However, the impact of COPD on public health can be alleviated by prevention and appropriate management using methods based on the latest evidence available. The newest version of the GOLD COPD strategy takes into account research from 2018 and 2019, explains the use of blood eosinophil counts as a biomarker for the efficacy of inhaled corticosteroids, and includes new algorithms for management cycle and follow-up pharmacological treatment.
This updated Guidelines summary provides evidence-based advice on the prevention, diagnosis, and management of COPD in primary care.